The San Diego Union-TribuneCancer-fighting cells activated with ultrasoundThe San Diego Union-TribuneResearchers from the University of Southern California and Memorial Sloan Kettering Cancer Center in New York also participated in the study, along wit… Continue reading
WQAD.comYOUR HEALTH: A stem cell treatment could help stroke victims recover quickerWQAD.comShe was helicoptered to the hospital and into the care of Dr. Wayne Clark. He asked if she wanted to be part of a trial for a stem cell treatment that might hel… Continue reading
MIT Technology ReviewUS Doctors Plan to Treat Cancer Patients Using CRISPRMIT Technology ReviewThe first human test in the U.S. involving the gene-editing tool CRISPR could begin at any time and will employ the DNA cutting technique in a bid to battle … Continue reading
|
Commercially Promising Stem Cell Research Projects Land State Funding
Twin Cities Business Magazine This new method is a form of cell transplantation utilizing the patient’s own cells, so it does not require immunosuppressive drugs. Dr. Troy Lund, University of Minnesota Stem Cell Institute. Dr. Lund’s research focuses improving the outcomes of … |
|
Lucigen Inks Global Distribution Deals
GenomeWeb The Madison, Wisconsin-based firm’s products support drug and therapeutic discovery, personalized medicine, synthetic biology, and point-of-care diagnostics. Last year Lucigen was also named sole distributor of Illumina’s Epicentre genomics kits … |
Washington Post |
Targeting Biotech’s 1%, China Speeds Into Gene Therapy: Gadfly
Washington Post China wants to go big on biotech and already is marching into experimental gene therapy. Last year marked a milestone in cancer treatment: In August, the U.S. FDA approved Novartis AG’s Kymriah, a CAR-T therapy for children with acute lymphoblastic … |
|
China’s Great Leap Into Biotech
Bloomberg China wants to go big on biotech and already is marching into experimental gene therapy. Last year marked a milestone in cancer treatment: In August, the U.S. FDA approved Novartis AG’s Kymriah, a CAR–T 1 therapy for children with acute lymphoblastic … |